Skip to main content

Table 3 Univariate and multivariate analyses of the association between the overall survival of 137 patients with colorectal cancer

From: Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer

Variables

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Age

1.12 (0.94-1.31)

0.576

  

Gender

0.99 (0.87-1.14)

0.834

  

Tumor size

1.41 (1.13-1.68)

0.033

1.04 (0.89-1.18)

0.473

Depth of wall invasion

1.33 (0.98-1.70)

0.065

  

Lymph node metastasis

1.47 (1.08-1.85)

0.014

1.24 (0.96-1.47)

0.085

Distant metastasis

1.54 (1.22-1.92)

0.007

1.38 (1.12-1.63)

0.006*

TNM stage

1.67 (1.39-1.94)

<0.001

1.48 (1.15-1.77)

0.004*

Differentiation

1.41 (1.18-1.65)

0.009

1.26 (1.02-1.51)

0.041*

Adjuvant chemotherapy

1.37 (1.05-1.74)

0.023

1.14 (0.91-1.39)

0.093

PSF3 expression

1.59 (1.26-1.95)

<0.001

1.35 (1.10-1.64)

0.002*

  1. CI confidence interval, HR hazard ratio, PSF3 partner of Sld five 3.
  2. *Significant P-value in multivariate analysis.